Gulf War Syndrome: Questions, Some Answers, and the Future of Deployment Surveillance

Chemical Warfare Agents: Toxicity at Low Levels

Volumn , Issue , 2000, Pages 261-299

  Weese, Coleen Baird ^a  

^a U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1942522602     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420041576-12     Document Type: Chapter

References (72)

1. Hyams, K.C., Wignall S.W., and Roswell, R., War syndromes and their evaluation: From the U.S. Civil War to the Persian Gulf War, Ann. Intern. Med., 125, 398, 1996.
2. Institute of Medicine, Veterans and Agent Orange, National Academy of Sciences, National Academy Press, Washington DC, 1996.
3. Defense Science Board, Report of the Defense Science Board Task Force on Persian Gulf War Health Effects, Office of the Under Secretary of Defense for Acquisition and Technology, Washington, DC, 1994.
4. NIH Technology Assessment Workshop Panel, The Persian Gulf Experience and Health, JAMA, 272, 391, 1994.
5. Institute of Medicine, Committee to Review the Health Consequences of Service during the Persian Gulf War, Medical Follow-up Agency, Health Consequences of Service during the Persian Gulf War: Initial Findings and Recommendations for Immediate Action, National Academy Press, Washington, DC, 1995.
6. Institute of Medicine, Committee to Review the Health Consequences of Service during the Persian Gulf War, Medical Follow-up Agency, Health Consequences of Service during the Persian Gulf War: Recommendations for Research and Information Systems, National Academy Press, Washington, DC, 1996.
7. Presidential Advisory Committee on Gulf War Veterans’ Illnesses, Special Report, U.S. Government Printing Office, Washington, DC, October 1997.
8. Presidential Advisory Committee on Gulf War Veteran’s Illnesses: Final Report, U.S. Government Printing Office, Washington, DC, December 1996.
9. Government Accounting Office, Gulf War Illnesses: Improved Monitoring of Clinical Progress and Reexamination of Research Emphasis Are Needed, GAO/NSAID-97-163, June 23, 1997.
10. Tyler, C.W., Jr. and Last, J.M., Epidemiology, in Maxcy-Rosenau-Last Public Health and Preventive Medicine, Last, J.M. and Wallace, R.B., Eds., 13th Ed., Appleton and Lange, 1991, 12.
11. National Research Council, Environmental Epidemiology: Public Health and Hazardous Wastes, Vol. 1, National Academy Press, Washington, DC, 1991.
12. Kang, H.K. and Bullman, T.A., Mortality among U.S. veterans of the Persian Gulf War, N. Eng. J. Med., 335, 1498, 1996.
13. Gray, G.C., Coate, B.D., Andeson, C.M., et al., The post-war hospitalization experience of U.S. veterans of the Persian Gulf War, N. Engl. J. Med., 335, 1505, 1996.
14. The Iowa Persian Gulf Study Group, Self-reported illness and health status among Gulf War veterans: A population based study, JAMA, 277, 238, 1997.
15. Cowan, D.N., DeFraites, R.F., Gray, G., Goldenbaum, M., and Wishik, S.M., The risk of birth defects among children of Gulf War veterans, N. Eng. J. Med., 336, 1650, 1997.
16. Penham, A.D. and Tarver, R.S., No evidence of increase in birth defects and health problems among children born to Persian Gulf War veterans in Mississippi, Mil. Med., 161(1), 1, 1996.
17. Writer, J.V., DeFraites, R.F., and Brundage, J.F., Comparative mortality among U.S. military personnel in the Persian Gulf and worldwide during Operations Desert Shield and Desert Storm, JAMA, 275, 18, 1996.
18. Kang, H.K. and Bullman, T.A., Mortality among U.S. veterans of the Gulf War: Update through December 1997, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veteran’s Research, June 23-25, 1999.
19. Haley, R., Commentaries, Point: Bias from the “healthy warrior effect” and unequal follow- up in three government studies of health effects of the Gulf War, Am. J. Epidemiol., 148, 315, 1998.
20. Kang, H. and Bullman, T., Counterpoint: Negligible “healthy warrior effect” on Gulf War veterans mortality, Am. J. Epidemiol., 148, 324, 1998.
21. Gray, G.C., Knoke, J., Berg, S.W., Wignall, S., and Barrett-Conner, E., Counterpoint: Responding to suppositions and misunderstandings, Am. J. Epidemiol., 148, 328, 1998.
22. The Iowa Persian Gulf Study Group, Self-reported illness and health status among Gulf War veterans: A population-based study, JAMA, 277, 238, 1997.
23. Eisen, S.A., Kang, H.K., and Murphy, F., Update on VA Cooperative Study #458, National Health Survey of Gulf War Era veterans and their families, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veterans’ Research, June 23-25, 1999.
24. Araneta, M.R., Destiche, D.A., Schlangen, K.M., Merz, R.D., Forrester, M.B., and Gray, G.C., Birth defects prevalence among infants of Gulf War veterans born in Hawaii, 1989-1993, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veterans’ Research, June 23-25, 1999.
25. DeFraites, R.F., Wanat, E.R., and Norwood, A.E., Report, investigation of a suspected outbreak of an unknown disease among veterans of Operation Desert Shield/Storm, 123d Army Reserve Command, Fort Benjamin Harrison, IN, April 1992, Epidemiology Consultant Service (EPICON), Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, DC, June 15, 1992.
26. Centers for Disease Control and Prevention, Unexplained illness among Persian Gulf War veterans in an Air National Guard Unit: Preliminary report-August 1990-March 1995, MMWR Morb Mortal Wkly Rep., 44, 443, 1995.
27. Berg, W., Post-Persian Gulf Medical findings: Naval mobile construction Battalion 24, presentation to the NIH Technology Assessment Workshop Panel on the Persian Gulf Experience and Health, Bethesda, MD, April 1994.
28. Haley, R.S., Kurt, T.L., and Hom, J., Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms, JAMA, 277, 1997.
29. Haley, R.W., Hom, J., Roland, P.S., et al., Evaluation of neurological function in Gulf War veterans: A blinded case-control study, JAMA, 277, 223, 1997.
30. Kotler-Cope, S., Milby, J.B., et al., Neuropsychological deficits in Persian Gulf War veterans: A preliminary report, presented at the annual meeting of the International Neuropsychological Society, Chicago, IL, 1996.
31. Roht, L.R., Vernon, S.W., Wier, F.W., Pier, S.M., Sullivan, P., and Reed, L.J., Community exposure to hazardous waste disposal sites: Assessing reporting bias, Am. J. Epidemiol., 122 (3), 418, 1985.
32. Hopwood, D.G. and Guidotti, T.L., Recall bias in exposed subjects following a toxic exposure incident, Arch. Environ. Health, 43, 234, 1988.
33. Baker, M.S. and Strunk, H.K., Medical aspects of Persian Gulf operations: Serious infections and communicable diseases of the Persian Gulf and Saudi Arabian Peninsula, Mil. Med., 156, 385, 1991.
34. Gasser, R.A., Magill, A.J., Oster, C.N., et al., The threat of infectious disease in Americans returning from Operation Desert Storm, New Eng. J. Med., 324(12), 859, 1991.
35. Hyams, K.C., Hanson, K., Wignall, F.S., et al., The impact of infectious diseases on the health of U.S. troops deployed to the Persian Gulf during Desert Shield and Desert Storm, Clinic Infect. Dis., 20, 1497, 1995.
36. Magill, A.J., Grogl, M., and Gasser, R.A., Visceral infection caused by Leishmania Tropica in veterans of Operation Desert Storm, New Eng. J. Med., 328(19), 1383, 1993.
37. Operation Desert Shield/Desert Storm, History of Participation of the U.S. Army Environmental Hygiene Agency, Aberdeen Proving Ground, MD, August 7, 1990-December 31, 1991.
38. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 7, Depleted Uranium, 1999.
39. Mather, S., Depleted uranium, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veteran’s Research, June 23-25, 1999.
40. McDiarmid, M.A., Hooper, F.J., Squibb, K., and McPhaul, K., The utility of spot collection for urinary uranium determinations in depleted uranium exposed Gulf War veterans, Health Physics, 77, 261, 1999.
41. McDiarmid, M.A., Keogh, J., Hooper, F.J., McPhaul, K., Squibb, K., et al., unpublished data on health effects of depleted uranium on exposed Gulf War veterans.
42. U.S. Interagency Air Assessment Team, Kuwait Oil Fires, Interagency Interim Report, April 1991.
43. World Meteorological Organization, Report of the Second WMO Meeting to Assess the Response to and Atmospheric Effects of the Kuwait Oil Fires, WMO/TD-No 512, Geneva, Switzerland, May 1992.
44. U.S. Army Environmental Hygiene Agency, Final Report: Kuwait Oil Fire Risk Assessment Project, 5 May-3 December 1991, Report No. 39-26-L192-91, February 1994.
45. Gray, G.C., Smith, T.C., Knoke, J.D., and Heller, J.M., The postwar hospitalization experience of Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq, Am. J. Epidemiol., 150, 532, 1999.
46. Walpole, R.D. and Rostker, B., Modeling the Chemical Warfare Agent Release at the Khamisiyah Pit, Department of Defense, September 4, 1991, URL http://www.gulflink.osd.mil/cia{andlm}092297/.
47. Abou-Donia, M.B., Wilmarth, K.R., Jenson, K.F., Oehme, F.W., and Kurt, T.L., Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: Implications of Gulf War chemical exposures, J. Toxicol. Environ. Health., 48, 35, 1996.
48. McCain, W.C., Lee, R., and Johnson, M.S., Acute oral toxicity study of pyridostigmine bromide, DEET and permethrin in the laboratory rat, J. Toxicol. Environ. Health, 50, 101, 1996.
49. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 1, Infectious Diseases, 1999.
50. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 2, Pyridostigmine Bromide, 1999.
51. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 3, Immunizations, 1999.
52. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 4, Stress, 1999.
53. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 5, Chemical and Biological Warfare Agents, 1999.
54. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 6, Oil Well Fires, 1999.
55. National Defense Research Institute, RAND, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 8, Pesticides, 1999.
56. U.S. Department of Defense, Comprehensive Clinical Evaluation Program for Ants, Persian Gulf War Veterans: CCEP Report on 18, 598 Participants, U.S. Department of Defense, Washington, DC, 1996.
57. Kang, H.H., Dalager, N.A., and Lee, K.Y., Health Surveillance of Persian Gulf War Veterans-A Review of the DVA Persian Gulf Registry Data, Department of Veterans Affairs, Washington, DC.
58. Gray, G.C., Hawksworth, A.W., Smith, T.C., Kang, H.K., Knoke, J.D., and Gackstetter, G.D., Gulf War Veterans’ health registries. Who is most likely to seek evaluation, Am. J. Epidemiol., 148, 343, 1998.
59. Presidential Advisory Committee of Gulf War Veteran’s Illnesses. Final Report, U.S. Government Printing Office, Washington, DC, December 1996.
60. Institute of Medicine, Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program. Evaluation of the U.S. Department of Defense Persian Gulf Syndrome Comprehensive Clinical Evaluation Program, Committee on the DoD Persian Gulf Comprehensive Clinical Evaluation, National Academy Press, Washington, DC, 1996.
61. Guldager, B., The Danish Gulf War study, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veterans’ Illnesses Research, June 23-25, 1999.
62. Graham, J.T., Gulf War veterans’ health concerns in the United Kingdom, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veterans’ Research, June 23-25, 1999.
63. Fukuda, K., Straus, S., Hickie, I., et al., The chronic fatigue syndrome: A comprehensive approach to its definition and study, Ann. Int. Med., 121, 953, 1994.
64. Wolfe, S., Smythe, H., Yunus, M., et al., The American College of Rheumatology 1990 criteria for fibromyalgia, arthritis and rheumatism, Arthritis Rheum., 33, 160, 1990.
65. Hyams, K.C., Developing case definitions for symptom-based conditions: The problem of specificity, Am. J. Epidem, 20, 148, 1998.
66. Gerrity, T.R. and Fuessner, J.R., Emerging research on the treatment of Gulf War veterans’ illnesses, J. Occup. Environ. Med., 41(6), 440, 1999.
67. Gerrity, T. R., Update on federal research program, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veteran’s Research, June 23-25, 1999.
68. Gulf War Illnesses and Related Research at the Institute of Medicine, National Academy of Sciences, An overview of research and recommendations, presented at the Research Working Group Persian Gulf Veterans Coordinating Board Conference on Federally Sponsored Gulf War Veteran’s Research, June 23-25, 1999.
69. Department of the Army, Field Manual 100-14, Risk Management.
70. U.S. Army Center for Health Promotion and Preventive Medicine, Technical Guide 230 A: Short Term Chemical Exposure Guidelines for Deployed Military Personnel.
71. U.S. Army Center for Health Promotion and Preventive Medicine, Technical Guide 230 A: Short Term Chemical Exposure Guidelines for Deployed Military Personnel.
72. Hill, A.B., The environment and disease: Association or causation? Proc. R. Soc. Med., 58, 295, 1965.